Clinical Trial Update: A Study of CDX-0159 in Patients With Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Clinical trial update indicating that the Phase 2 study of CDX-0159 in eosinophilic esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• CDX-0159

Snippet

Sponsor: Celldex Therapeutics | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED